VIR shares rose more than 8% in premarket trading
Tiger Newspress2022-01-11
VIR shares rose more than 8% in premarket trading.The United States has agreed to buy 600,000 more doses of GSK and Vir Biotechnology's COVID-19 antibody therapy for an undisclosed sum, the drugmakers said on Tuesday, as the country bolsters its arsenal of treatments against the Omicron coronavirus variant.
The additional doses of sotrovimab would be supplied to the United States in the first quarter of 2022, the companies said, taking the tally of doses secured by nations worldwide to roughly 1.7 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.